Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis-Reference-Cited by-同舟云学术

Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis

Published:2017-06-01 Issue:30 Volume:8 Page:48563-48574
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Vasseur Philippe¹²,Dion Sarah³,Filliol Aveline³,Genet Valentine³,Lucas-Clerc Catherine⁴,Jean-Philippe Girard⁵,Silvain Christine²⁶,Lecron Jean-Claude²⁷,Piquet-Pellorce Claire³,Samson Michel³

Affiliation:

1. Service d'Hépato-Gastroentérologie, Centre Hospitalier Nord Deux-Sèvres, Thouars, France

2. Laboratoire Inflammation Tissus Epithéliaux et Cytokines, Université de Poitiers, Poitiers, France

3. Institut National de la Santé et de la Recherche Médicale, Institut de Recherche Santé Environnement & Travail, Université de Rennes, Rennes, France

4. Service de Biochimie, Centre Hospitalier Universitaire, Rennes, Université de Rennes, Rennes, France

5. Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Université de Toulouse, Toulouse, France

6. Service d'Hépato-Gastroentérologie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France

7. Service d'Immunologie et Inflammation, Centre Hospitalier Universitaire de Poitiers, Poitiers, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal IL-33 promotes microbiota-derived trimethylamine N-oxide synthesis and drives metabolic dysfunction–associated steatotic liver disease progression by exerting dual regulation on HIF-1α;Hepatology;2024-07-10

2. Endogenous IL-33 Accelerates Metacestode Growth during Late-Stage Alveolar Echinococcosis;Microbiology Spectrum;2023-04-13

3. Regulation of Progression and Resolution of Liver Fibrosis by Immune Cells;Seminars in Liver Disease;2022-10-08

4. Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update;Journal of Clinical and Translational Hepatology;2022-08-15

5. Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms;Journal of Molecular Medicine;2022-04-27